| HOME | ABOUT ACCESS TO INSIGHT |
ABOUT NOVO NORDISK |
GRANTS & AWARDS CORE FACULTY REVIEW BOARD |
GRANT | AWARDS | SCHOLARSHIP | WINNERS | CONTACT US |
Novo Nordisk Access to Insight is steered by an international Access to Insight Grants & Awards Core Faculty, a group of 4 distinguished haemostasis experts: Nigel Key (Chair), Christopher A. Ludlam, Paulo André Palhares de Miranda and Stephanie Seremetis. The Core Faculty members are dedicated to identifying the most promising applicants and ensuring a fair selection process.
Nigel Key and Christopher A. Ludlam have been involved in the development of the Access to Insight programme from the start, and the research scope, the application and review process, and the composition of the Review Board were finalised with their agreement. They, together with a Review Board of independent haemostasis experts, will select the winners only after all applications have undergone a detailed scientific peer review. Members of the Review Board are listed below. Paulo André Palhares de Miranda and Stephanie Seremetis represent Novo Nordisk Haemostasis Medical Affairs and Haemostasis Global Development, respectively. They serve as coordinators of the programme, and will also provide comments on incoming applications for the Faculty's consideration, but do not have voting power in the funding decision.
Your Access to Insight
“The Novo Nordisk Access to Insight programme will help dedicated
researchers to advance the understanding of haemostasis and improve
patient care. We hope to literally open new doors for the next
generation of physicians with an interest in bleeding disorders.”
Nigel Key, MB ChB, FRCP
Chair of the Access to Insight Grants & Awards Core Faculty
Chair of the Access to Insight Grants & Awards Core Faculty
Harold R. Roberts Comprehensive Hemophilia Diagnostic and Treatment Center, University of North Carolina School of Medicine at Chapel Hill, NC, USA
Nigel Key is currently the Harold R. Roberts Distinguished Professor at the University of North Carolina School of Medicine and Director of the Harold R. Roberts Comprehensive Hemophilia Diagnostic and Treatment Center in Chapel Hill, NC, USA.
A recipient of the Researcher of the Year Award from the National Hemophilia Foundation, Dr. Key is the current President of the Hemophilia and Thrombosis Research Society, a Council member of the International Society on Thrombosis and Haemostasis and an Executive Committee member of the World Federation of Hemophilia. His National Institutes of Health (NIH)-funded laboratory research is focused on the measurement of intravascular tissue factor in disease states. He is also a reviewer for numerous professional journals.
Professor of Haematology and Coagulation Medicine, Consultant Haematologist
Christopher Ludlam is Professor of Haematology and Coagulation Medicine at the University of Edinburgh and Director of the Haemophilia and Thrombosis Centre at the Royal Infi rmary of Edinburgh. Dr. Ludlam has been Chairman of the UK Haemophilia Centre Doctors’ Organisation and President of the British Society of Haemostasis and Thrombosis. He has served as chairman or a member of national committees advising on the provision of haemophilia and coagulation services in the UK and Europe. Recently he was Co-chairman of the European Interdisciplinary Working Group. Currently he is President of the European Association for Haemophilia and Allied Disorders. Over the past 25 years, his major activities have been towards promoting the development of safe therapeutic products for haemophilia.
Global Medical Director, Haemostasis
Global Marketing, Novo Nordisk, Zurich, Switzerland
Paulo André Palhares de Miranda is Medical Director of Haemostasis Global Medical Affairs at Novo Nordisk in Zurich, Switzerland. Before joining Novo Nordisk, Dr. Miranda was responsible for supervising transfusion practices, haematological care of haemophilia patients, including surgeries, and the outpatient clinic for coagulation disorders at the Hospital de Clínicas of the Federal University of Paraná in Curitiba, Brazil. During this time he also held the position of Haematologist and Medical Director of the Haematology and Transfusion Medicine Centre of Paraná, a regional blood bank and haemophilia care centre for the State of Paraná.
VP Medical and Science, Haemostasis
Global Development, Novo Nordisk, Bagsværd, Denmark
Stephanie Seremetis is Vice President for Medical and Science, in Haemostasis Global Development at Novo Nordisk. Dr. Seremetis was previously an associate professor in the Departments of Medicine and Geriatrics at the Mount Sinai School of Medicine in New York City, USA, where she also served as director of the Regional Comprehensive Hemophilia Diagnostic and Treatment Center. In addition, she was the founding director of the Women’s Health Program at Mount Sinai Medical Center, which successfully coordinated comprehensive clinical care, teaching and research inwomen’s health. In 2000, she was namedNational Hemophilia Foundation Physician of the Year, and she received the Project Red Flag Visionary Award by the National Hemophilia Foundation in 2008.
Professor in Thrombosis and Haemostasis
Centre for Haemophilia and Thrombosis,
Department of Clinical Biochemistry, Skejby University Hospital, Aarhus, Denmark
Professor
Department of Pediatrics,
Nara Medical University, Japan
William H. Bennett Professor of Pediatrics, University of Pennsylvania School of Medicine Investigator,
Howard Hughes Medical Institute Director, Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia, USA
Van Creveldkliniek, Dept of Haematology & Julius Center for Health Sciences and Primary Care
UMC Utrecht, The Netherlands
Professor of Haemophilia at University College London Haemophilia Centre, Royal Free Hospital, London, NW3 2QG, UK
Director of the Katharine Dormandy Haemophilia Centre in London, UK.
Assistant Physician - Department of Hematology of the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP)
Professor of Pediatric Hematology
Medical College of Wisconsin, USA
Department of Pediatrics Medical College of Wisconsin, USA
Blood Research Institute, Blood Centre of Wisconsin
Head of the National Haemophilia Centre and Head of the Research and Teaching Department at the Banco Metropolitano de Sangre in Caracas, Venezuela.
Chief of the Division of Haematology/Oncology at the Hospital for Sick Children and Professor of Paediatrics at the University of Toronto
Professor of Medicine
Claude Bernard University of Lyon, France
Chairman of the Hematology Division at Edouard Herriot University Hospital Hemophilia and Thrombosis Comprehensive Care Center
